Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients

B. Goorts, Thiemo J. A. van Nijnatten, Linda de Munck, +5

Breast Cancer Research and Treatment

Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research

M. Moossdorff, Lori M. van Roozendaal, Luc J. A. Strobbe, +23

JNCI Journal of the National Cancer Institute

Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

Thiemo J. A. van Nijnatten, Janine M. Simons, M. Moossdorff, +6

Breast Cancer Research and Treatment

A Model to Predict Pathologic Complete Response of Axillary Lymph Nodes to Neoadjuvant Chemo(Immuno)Therapy in Patients With Clinically Node-Positive Breast Cancer

Robert‐Jan Schipper, M. Moossdorff, Patty J. Nelemans, +9

Clinical Breast Cancer

Breast OncologyMedicineImmunologyPathologyImmune Checkpoint Inhibitor +5

International consensus statement regarding the use of animal models for research on anastomoses in the lower gastrointestinal tract

Joanna W. A. M. Bosmans, M. Moossdorff, Mahdi Al‐Taher, +3

International Journal of Colorectal Disease

Animal PhysiologyInternational Consensus StatementLower Gastrointestinal TractPhysiologyGastroenterology +6

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years

Marissa C. van Maaren, Luc J. A. Strobbe, Marjolein L. Smidt, +3

European Journal of Cancer

Surgical OncologyBreast OncologyBreast Cancer PatientsMedicineCancer Recurrence +8

The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy

M. Moossdorff, Faina Nakhlis, Jiani Hu, +5

Annals of Surgical Oncology

Potential ImpactSurgical OncologyBreast OncologyMedicineCancer Management +6

Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study

Thiemo J. A. van Nijnatten, Robert‐Jan Schipper, Marc B. I. Lobbes, +9

Clinical Radiology

EngineeringMedical ImagingBreast Cancer PatientsBiomedical ImagingBreast Imaging +8

TNM classification and the need for revision of pN3a breast cancer

Thiemo J. A. van Nijnatten, M. Moossdorff, Linda de Munck, +6

European Journal of Cancer

Breast OncologyOncologyMedicinePathologyCancer Genomics +9

Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?

Vera Habraken, Thiemo J. A. van Nijnatten, Linda de Munck, +4

Breast Cancer Research and Treatment